Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Barrett's esophagus
MedTech
Exact shows off its pill-on-a-string test for esophageal cancer
The Oncoguard Esophagus test, developed with the Mayo Clinic, searches for DNA biomarkers tied to esophageal adenocarcinoma and Barrett’s esophagus.
Conor Hale
Mar 28, 2024 11:00am
Castle Bio taps into Cernostics' GI franchise with $80M deal
Oct 19, 2021 1:26pm
Lucid Diagnostics files for $58M IPO to leave the PAVmed nest
Sep 23, 2021 11:54am
Insights into esophageal cancer could boost early detection
Aug 12, 2021 2:00pm
Lucid's DNA test for esophageal cancer lands EU approval
Jun 14, 2021 8:40am
PAVmed licenses Barrett’s esophagus diagnostic
May 14, 2018 11:06am
